Showing results (51-60 of 378) with videos related to
Sort By:
Pageof 38
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2025
Was it Worth It? Response Data from >650 United States and International Participants in Chemoprevention TrialsDavid Zahrieh, Carrie A Strand, Paul J Limburg, et al.Statistics in Medicine|January 22, 2013
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicitiesMonia Ezzalfani, Sarah Zohar, Rui Qin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesDipesh Uprety, Sumithra J Mandrekar, Dennis Wigle, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2018
Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical ConsiderationsJennifer Le-Rademacher, Suzanne Dahlberg, J Jack Lee, et al.JAMA Oncology|June 22, 2023
Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical TrialsShauna L Hillman, Aminah Jatoi, Carrie A Strand, et al.Journal of Biopharmaceutical Statistics|July 12, 2023
Statistical Considerations and Software for Designing Sequential, Multiple Assignment, Randomized Trials (SMART) with a Survival Final EndpointSasha Kravets, Amy S Ruppert, Sawyer B Jacobson, et al.Cancer|January 11, 2007
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trialsMashele M Huschka, Sumithra J Mandrekar, Paul L Schaefer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Guidelines for Statistical Reporting in Medical JournalsFang-Shu Ou, Jennifer G Le-Rademacher, Karla V Ballman, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 10, 2020
Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical TrialsQuyen Duong, Sumithra J Mandrekar, Stacey J Winham, et al.Journal of Patient Experience|June 27, 2022
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded studyJana Wieland, Daniel Satele, Yahya Almodallal, et al.Pageof 38